Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Multiple pharmacy

Three-quarters of Rowlands pharmacies could cut opening hours under money-saving proposals

Pheonix Medical Supplies, the parent company of Rowlands Pharmacy, has announced plans to cut back on opening hours by ten hours per branch each week.

Rowlands pharmacy


Some 75% of Rowlands Pharmacy branches are currently open for longer than the 40 hours that are contractually required per week

Rowlands Pharmacy has proposed cutting back on the number of hours its pharmacies are open for in an effort to cut costs.

In an announcement made on 2 March 2020, Rowlands Pharmacy’s parent company, Phoenix Medical Supplies, said that 75% of its pharmacies are currently open for longer than the 40 hours that are contractually required per week, which, it added, was a cost the company “can no longer sustain”.

As a result, it said the company was consulting with branch staff over plans to cut back on opening hours by ten hours per branch each week, with a final decision expected by the end of March 2020.

The statement said that the changes were “a direct consequence of the funding austerity facing community pharmacy in England, which has made the network economically unsustainable”.

“Government funding for community pharmacy in England has been capped over the next five years which, in real terms, taking account of rising costs and inflation, means a reduction in funding,” it added.

In July 2019, the government and pharmacy negotiators announced in the community pharmacy contractual framework for 2019/2020 to 2023/2024 that funding would be capped at £2.59bn per year for the next five years.

A spokesperson for Rowlands Pharmacy would not confirm to The Pharmaceutical Journal how much the company hopes to save by reducing opening hours, but said it expects the impact on customers to be “minimal”.

“Rowlands reiterates that, with a pledge of £34bn in new funding for the NHS, now is the time for the government to invest in community pharmacy and reverse the decline in the network which has seen hundreds of pharmacies close at a time when GP surgeries and A&E departments are struggling to cope with demand,” the statement said.

In February 2019, the company announced plans to sell 70 of its pharmacies in order to “invest in the future”.

The announcement from Rowlands Pharmacy on cutting back hours comes on the same day that Boots announced that it would be selling 44 pharmacies as part of its ongoing plans to divest of 200 stores by 2021.

Boots announced plans to close 200 stores in June 2019 due to “difficult market conditions in the UK”, with 28 of these having closed as of 8 January 2020.

The 44 Boots pharmacies will be sold via specialist business property advisers by May 2020 as going concerns and will include all stock, fixtures and fittings.

Tony Evans, head of pharmacy at Christie & Co., said the dispensing volumes of the pharmacies for sale range from 1,100 to more than 9,000 items per month and “occupy either community, high street or health centre environments”.

Tracey Clements, chief operating officer at Boots, said: “The decision to sell or close a pharmacy is never easy, but we are continuing to invest in our wider store network by making our retail, pharmacy and online offer even more differentiated and personalised, with the best brands at the best value.”

She added that Boots is supporting pharmacy staff in the affected stores “and are keeping them fully updated on the potential sale of their store”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20207774

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.